文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

单核细胞分布宽度作为感染诊断标志物的系统评价与荟萃分析

Monocyte Distribution Width as a Diagnostic Marker for Infection: A Systematic Review and Meta-analysis.
PubMed 文献 · Chest · 2023-01-18
一句话结论单核细胞分布宽度(MDW)对脓毒症和COVID-19诊断性能良好,脓毒症诊断阈值的选择应考虑所用参考标准和采血管类型。

该研究是一项系统评价与荟萃分析,检索PubMed、Embase、Scopus和Web of Science至2022年2月4日,纳入29项研究,其中19项针对脓毒症、6项针对COVID-19。采用线性混合效应模型汇总诊断性能指标。脓毒症汇总AUC因参考标准(脓毒症与脓毒性休克第二次 vs 第三次国际共识定义)和采血管抗凝剂不同而异,范围为0.74~0.94,平均敏感度0.69~0.79,平均特异度0.57~0.86;COVID-19汇总AUC为0.76,平均敏感度0.79,平均特异度0.59。作者认为MDW对脓毒症和COVID-19诊断性能良好,脓毒症诊断阈值应结合参考标准和采血管类型选择。

要点

  • MDW作为血常规(CBC)的一部分,可在入院时常规、快速获得。
  • 脓毒症:汇总AUC因参考标准和采血管抗凝剂不同而异,范围0.74~0.94。
  • 脓毒症:平均敏感度0.69~0.79,平均特异度0.57~0.86。
  • COVID-19:汇总AUC 0.76,平均敏感度0.79,平均特异度0.59。
  • 脓毒症诊断阈值的选择应考虑所用参考标准(第二次 vs 第三次国际共识定义)和采血管类型。

适用人群与场景

  • 多种感染性疾病结局和诊疗场景(原文为跨多种感染性疾病结局和诊疗场景的系统评价)

研究设计与关键结果

  • 系统评价与荟萃分析,检索PubMed、Embase、Scopus和Web of Science至2022年2月4日,纳入29项研究。
  • 多数研究针对脓毒症(19项)和COVID-19(6项)。
  • 脓毒症汇总诊断性能因参考标准(脓毒症与脓毒性休克第二次 vs 第三次国际共识定义)和采血管抗凝剂不同而异,AUC范围0.74~0.94,平均敏感度0.69~0.79,平均特异度0.57~0.86。
  • COVID-19:MDW汇总AUC 0.76,平均敏感度0.79,平均特异度0.59。
  • 仅对报告数≥3的结局(脓毒症和COVID-19)进行荟萃分析;单项研究诊断性能指标单独计算,汇总估计由线性混合效应模型生成。

证据类型、等级与局限

  • 证据类型:系统评价与荟萃分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为MDW对脓毒症和COVID-19诊断性能良好。
  • 作者认为脓毒症诊断阈值的选择应考虑所用参考标准和采血管类型。

指南或共识出处

  • PROSPERO注册号CRD42020210074

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Monocyte distribution width (MDW) is an emerging biomarker for infection. It is available easily and quickly as part of the CBC count, which is performed routinely on hospital admission. The increasing availability and promising results of MDW as a biomarker in sepsis has prompted an expansion of its use to other infectious diseases.

RESEARCH QUESTION: What is the diagnostic performance of MDW across multiple infectious disease outcomes and care settings?

STUDY DESIGN AND METHODS: A systematic review of the diagnostic performance of MDW across multiple infectious disease outcomes was conducted by searching PubMed, Embase, Scopus, and Web of Science through February 4, 2022. Meta-analysis was performed for outcomes with three or more reports identified (sepsis and COVID-19). Diagnostic performance measures were calculated for individual studies with pooled estimates created by linear mixed-effects models.

RESULTS: We identified 29 studies meeting inclusion criteria. Most examined sepsis (19 studies) and COVID-19 (six studies). Pooled estimates of diagnostic performance for sepsis differed by reference standard (Second vs Third International Consensus Definitions for Sepsis and Septic Shock criteria) and tube anticoagulant used and ranged from an area under the receiver operating characteristic curve (AUC) of 0.74 to 0.94, with mean sensitivity of 0.69 to 0.79 and mean specificity of 0.57 to 0.86. For COVID-19, the pooled AUC of MDW was 0.76, mean sensitivity was 0.79, and mean specificity was 0.59.

INTERPRETATION: MDW exhibited good diagnostic performance for sepsis and COVID-19. Diagnostic thresholds for sepsis should be chosen with consideration of reference standard and tube type used.

TRIAL REGISTRY: Prospero; No.: CRD42020210074; URL: https://www.crd.york.ac.uk/prospero/.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Malinovska A, Hernried B, Lin A, et al. Monocyte Distribution Width as a Diagnostic Marker for Infection: A Systematic Review and Meta-analysis. Chest. 2023. PMID: 36681146. doi:10.1016/j.chest.2022.12.049

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。